Effect of renal sympathetic denervation on the progression of paroxysmal atrial fibrillation in canines with long-term intermittent atrial pacing

Europace

Volumn 17, Issue 4, 2015, Pages 647-654

  Wang, Xule ^a,b   Huang, Congxin ^a,b   Zhao, Qingyan ^a,b   Huang, He ^a,b   Tang, Yanhong ^a,b   Dai, Zixuan ^a,b   Wang, Xiao Zhan ^a,b   Guo, Zongwen ^a,b   Xiao, Jinping ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

Author keywords

Ablation; Atrial electrophysiology; Atrial fibrillation; Heterogeneity; Renal sympathetic nerve

Indexed keywords

ALDOSTERONE; ANGIOTENSIN II; CONNEXIN 43;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEAGLE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART ELECTROPHYSIOLOGY; HEART HEMODYNAMICS; IMMUNOHISTOCHEMISTRY; KIDNEY DENERVATION; NONHUMAN; P WAVE; PRIORITY JOURNAL; SYMPATHETIC NERVE; ANIMAL; ATRIAL FIBRILLATION; DOG; INNERVATION; KIDNEY; MULTIMODALITY CANCER THERAPY; PROCEDURES; SURGERY; SYMPATHECTOMY; TREATMENT OUTCOME;

ANIMALS; ATRIAL FIBRILLATION; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DOGS; KIDNEY; SYMPATHECTOMY; TREATMENT OUTCOME;

EID: 84926640492     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu212     Document Type: Article

References (30)

1. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K et al. Catheterbased renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009;373:1275-81.
2. Symplicity HTN-2 Investigators, Esler MD, Krum H, Sobotka PA, Schlaich MP, Schmieder RE et al. Renal sympathetic denervation in patients with treatmentresistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010;376:1903-9.
3. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med 2014;370:1393-401.
4. Davies JE, Manisty CH, Petraco R, Barron AJ, Unsworth B, Mayet J et al. First-in-man safety evaluation of renal denervation for chronic systolic heart failure: primary outcome from REACH-Pilot study. Int J Cardiol 2013;162:189-92.
5. Brandt MC, Mahfoud F, Reda S, Schirmer SH, Erdmann E, BöhmM et al. Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. J Am Coll Cardiol 2012;59:901-9.
6. Linz D, Mahfoud F, Schotten U, Ukena C, Neuberger HR, Wirth K et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension 2012;60:172-8.
7. Pokushalov E, Romanov A, Corbucci G, Artyomenko S, Baranova V, Turov A et al. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension. J Am Coll Cardiol 2012;60:1163-70.
8. Linz D, Mahfoud F, Schotten U, Ukena C, Hohl M, Neuberger HR et al. Renal sympathetic denervation provides ventricular rate control but does not prevent atrial electrical remodeling during atrial fibrillation. Hypertension 2013;61:225-31.
9. Hu J, Ji M, Niu C, Aini A, Zhou Q, Zhang L et al. Effects of renal sympathetic denervation on post-myocardial infarction cardiac remodeling in rats. PLoS ONE 2012;7:e45986. doi:10.1371/journal.pone.0045986.
10. Zhao Q, Yu S, Zou M, Dai Z, Wang X, Xiao J et al. Effect of renal sympathetic denervation on the inducibility of atrial fibrillation during rapid atrial pacing. J Interv Card Electrophysiol 2012;35:119-25.
11. Wang X, Zhao Q, Huang H, Tang Y, Xiao J, Dai Z et al. Effect of renal sympathetic denervation on atrial substrate remodeling in ambulatory canines with prolonged atrial pacing. PLoS ONE 2013;8:e64611. doi:10.1371/journal.pone.0064611.
12. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med 2009;361:932-4.
13. Dilaveris PE, Gialafos EJ, Sideris SK, Theopistou AM, Andrikopoulos GK, KyriakidisM et al. Simple electrocardiographic markers for the prediction of paroxysmal idiopathic atrial fibrillation. Am Heart J 1998;135:733-8.
14. Dilaveris PE, Gialafos EJ, Andrikopoulos GK, Richter DJ, Papanikolaou V, Poralis K et al. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol 2000;23:352-8.
15. Yamada T, Fukunami M, Shimonagata T, Kumagai K, Sanada S, Ogita H et al. Dispersion of signal-averaged Pwave duration on precordial body surface in patients with paroxysmal atrial fibrillation. Eur Heart J 1999;20:211-20.
16. Koide Y, YotsukuraM, Ando H, Aoki S, Suzuki T, Sakata K et al. Usefulness of P-wave dispersion in standard twelve-lead electrocardiography to predict transition from paroxysmal to persistent atrial fibrillation. Am J Cardiol 2008;102:573-7.
17. Bissinger A, Grycewicz T, Grabowicz W, Lubinski A. The effect of diabetic autonomic neuropathy on P-wave duration, dispersion and atrial fibrillation. Arch Med Sci 2011;7:806-12.
18. Hashemi Jazi M, Amirpour A, Zavvar R, Behjati M, Gharipour M. Predictive value of P-wave duration and dispersion in post coronary artery bypass surgery atrial fibrillation. ARYA Atheroscler J 2012;8:59-62.
19. Ehrlich JR, Schadow K, Steul K, Zhang GQ, IsraelCW, Hohnloser SH. Prediction of early recurrence of atrial fibrillation after external cardioversion by means of Pwave signal-averaged electrocardiogram. Z Kardiol 2003;92:540-6.
20. Buber J, Luria D, Sternik L, Kuperstein R, Grupper A, Goldenberg I et al. Morphological features of the P-waves at surface electrocardiogram as surrogate to mechanical function of the left atrium following a successful modified maze procedure. Europace 2014;16:578-86.
21. Blanche C, Tran N, Rigamonti F, Burri H, Zimmermann M. Value of P-wave signal averaging to predict atrial fibrillation recurrences after pulmonary vein isolation. Europace 2013;15:198-204.
22. Masuda M, Inoue K, Iwakura K, Okamura A, Toyoshima Y, Doi A et al. Impact of pulmonary vein isolation on atrial late potentials: association with the recurrence of atrial fibrillation. Europace 2013;15:501-7.
23. Sih HJ, Zipes DP, Berbari EJ, Adams DE, Olgin JE. Differences in organization between acute and chronic atrial fibrillation in dogs. J Am Coll Cardiol 2000;36: 924-31.
24. Matsuo S, Lellouche N, Wright M, Bevilacqua M, Knecht S, Nault I et al. Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J Am Coll Cardiol 2009;54:788-95.
25. Gaspo R, Bosch RF, Talajic M, Nattel S. Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model. Circulation 1997;96:4027-35.
26. Limantoro I, de Vos CB, Delhaas T,Weijs B, Blaauw Y, Schotten U et al. Clinical correlates of echocardiographic tissue velocity imaging abnormalities of the left atrial wall during atrial fibrillation. Europace 2014;16:1546-53.
27. Allessie M, Ausma J, Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002;54:230-46.
28. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol 2008;51:802-9.
29. Schoonderwoerd BA, Van Gelder IC, Van Veldhuisen DJ, Van den BergMP, Crijns HJ. Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation. Prog Cardiovasc Dis 2005;48:153-68.
30. Goudis CA, Kallergis EM, Vardas PE. Extracellular matrix alterations in the atria: insights into the mechanisms and perpetuation of atrial fibrillation. Europace 2012; 14:623-30.